CHARLES SCHWAB INVESTMENT MANAGEMENT INC - SUTRO BIOPHARMA INC ownership

SUTRO BIOPHARMA INC's ticker is STRO and the CUSIP is 869367102. A total of 137 filers reported holding SUTRO BIOPHARMA INC in Q4 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.4%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of SUTRO BIOPHARMA INC
ValueSharesWeighting
Q3 2023$558,240
-25.4%
160,8760.0%0.00%
Q2 2023$748,073
+11.0%
160,876
+10.2%
0.00%
Q1 2023$674,243
-42.1%
145,940
+1.2%
0.00%
Q4 2022$1,164,708
+59.8%
144,147
+9.9%
0.00%
Q3 2022$729,000
+16.6%
131,205
+9.5%
0.00%
Q2 2022$625,000
-36.5%
119,783
+0.1%
0.00%
Q1 2022$984,000
-39.7%
119,667
+9.2%
0.00%
Q4 2021$1,631,000
-20.0%
109,549
+1.6%
0.00%
-100.0%
Q3 2021$2,038,000
+5.4%
107,873
+3.7%
0.00%0.0%
Q2 2021$1,934,000
+4.4%
103,998
+27.8%
0.00%0.0%
Q1 2021$1,853,000
+21.5%
81,398
+15.9%
0.00%0.0%
Q4 2020$1,525,000
+130.4%
70,225
+6.6%
0.00%
Q3 2020$662,000
+76.5%
65,859
+36.5%
0.00%
Q2 2020$375,000
+62.3%
48,231
+113.5%
0.00%
Q1 2020$231,000
-7.2%
22,5920.0%0.00%
Q4 2019$249,000
+20.9%
22,5920.0%0.00%
Q3 2019$206,000
-20.2%
22,5920.0%0.00%
Q2 2019$258,000
+72.0%
22,592
+72.3%
0.00%
Q1 2019$150,000
+26.1%
13,1100.0%0.00%
Q4 2018$119,00013,1100.00%
Other shareholders
SUTRO BIOPHARMA INC shareholders Q4 2020
NameSharesValueWeighting ↓
Samsara BioCapital, LLC 1,675,579$5,814,2591.78%
SUVRETTA CAPITAL MANAGEMENT, LLC 5,883,693$20,416,4151.10%
Kynam Capital Management, LP 1,552,675$5,387,7820.88%
Parkman Healthcare Partners LLC 1,182,168$4,102,1230.75%
Rubric Capital Management LP 3,344,810$11,606,4910.44%
BVF INC/IL 3,347,946$11,617,3730.31%
DAFNA Capital Management LLC 283,079$982,2840.31%
SECTORAL ASSET MANAGEMENT INC 432,339$1,500,2160.29%
Eversept Partners, LP 769,638$2,670,6440.23%
Frazier Life Sciences Management, L.P. 780,000$2,706,6000.18%
View complete list of SUTRO BIOPHARMA INC shareholders